Korro Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	61.7	21.82	55.64	166.15	36.33	79.64
Short-Term Investments	52.27	53.33	70.45	-	18.92	51.07
Cash & Short-Term Investments	113.97	75.16	126.1	166.15	55.25	130.71
Cash Growth	-0.85%	-40.40%	-24.11%	200.74%	-57.73%	-40.68%
Accounts Receivable	-	0.97	1.7	-	-	-
Other Current Assets	6.19	6.25	3.74	6.58	1.84	4.04
Total Current Assets	120.16	82.37	131.53	172.73	57.08	134.75
Net Property, Plant & Equipment	15.62	16.22	51.55	42.82	11.89	36.87
Long-Term Investments	43.08	10.03	36.96	-	-	11.72
Other Long-Term Assets	4.76	4.88	6.2	6.12	4.77	2.02
Total Assets	183.62	113.51	226.24	221.66	73.74	185.36
Accounts Payable	1.96	1.65	3.99	7.28	2.61	2.75
Accrued Expenses	9.85	7.61	6.17	10.21	3.18	6.1
Current Portion of Long-Term Debt	-	-	-	-	-	0.83
Current Portion of Leases	2.8	2.67	1.28	1.99	2.92	1.75
Unearned Revenue	0.18	-	3.51	-	-	-
Total Current Liabilities	14.79	11.94	14.96	19.48	8.7	11.43
Long-Term Debt	-	-	-	-	-	14.17
Long-Term Leases	40.08	40.81	43.48	31.22	0.21	28.85
Other Long-Term Liabilities	9.12	9.32	7.38	1.05	-	0.09
Total Long-Term Liabilities	49.2	50.13	50.87	32.27	0.21	43.11
Total Liabilities	63.99	62.07	65.83	51.75	8.91	54.53
Common Stock	0.01	0.01	0.01	0.01	-	0.04
Additional Paid-in Capital	523.09	435.06	426.72	352.91	-	310.94
Accumulated Other Comprehensive Income	0.01	0.21	0.27	-	-	-0.06
Retained Earnings	-403.47	-383.85	-266.59	-183.01	-	-180.09
Total Common Shareholders' Equity	119.63	51.44	160.42	169.91	-	130.82
Minority Interest	-	-	-	-	163.86	-
Shareholders' Equity	119.63	51.44	160.42	169.91	163.86	130.82
Total Liabilities & Equity	183.62	113.51	226.24	221.66	172.77	185.36
Total Debt	42.89	43.49	44.77	33.21	3.13	45.6
Net Cash (Debt)	71.09	31.67	81.33	132.94	52.12	85.11
Net Cash Growth	124.45%	-61.06%	-38.82%	155.08%	-38.76%	-51.18%
Net Cash Per Share	7.14	3.37	9.12	86.93	80.80	131.94
Book Value	119.63	51.44	160.42	169.91	0	130.82
Book Value Per Share	12.02	5.47	17.98	111.10	-	202.81
Tangible Book Value	119.63	51.44	160.42	169.91	0	130.82
Tangible Book Value Per Share	12.02	5.47	17.98	111.10	-	202.81

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q